139 related articles for article (PubMed ID: 4023730)
1. Bone changes from prostaglandin therapy.
Poznanski AK; Fernbach SK; Berry TE
Skeletal Radiol; 1985; 14(1):20-5. PubMed ID: 4023730
[TBL] [Abstract][Full Text] [Related]
2. Periosteal changes secondary to prostaglandin administration.
Ringel RE; Haney PJ; Brenner JI; Mancuso TJ; Roberts GS; Moulton AL; Berman MA
J Pediatr; 1983 Aug; 103(2):251-3. PubMed ID: 6683753
[No Abstract] [Full Text] [Related]
3. Prostaglandin-induced neonatal periostitis.
Letts M; Pang E; Simons J
J Pediatr Orthop; 1994; 14(6):809-13. PubMed ID: 7814600
[TBL] [Abstract][Full Text] [Related]
4. Bone formation induced in an infant by systemic prostaglandin-E2 administration.
Jørgensen HR; Svanholm H; Høst A
Acta Orthop Scand; 1988 Aug; 59(4):464-6. PubMed ID: 3166573
[TBL] [Abstract][Full Text] [Related]
5. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.
Gittenberger-de Groot AC; Moulaert AJ; Harinck E; Becker AE
Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973
[TBL] [Abstract][Full Text] [Related]
6. [Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].
van der Sijp JR; Rohmer J
Tijdschr Kindergeneeskd; 1985 Feb; 53(1):20-5. PubMed ID: 3857721
[TBL] [Abstract][Full Text] [Related]
7. Periosteal hyperostosis resulting from prostaglandin therapy.
Williams JL
Eur J Radiol; 1986 Aug; 6(3):231-2. PubMed ID: 3769947
[TBL] [Abstract][Full Text] [Related]
8. [Skeletal side effects of treatment with prostaglandin E1].
Persigehl M; Hövels-Gürich H; von Bernuth G
Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandins and the management of congenital heart disease.
Taylor WJ; Alpert BS
Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
[TBL] [Abstract][Full Text] [Related]
10. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
Park IS; Nihill MR; Titus JL
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
[No Abstract] [Full Text] [Related]
11. [Bone changes in infants induced by prostaglandin E1 as secondary hypertrophic osteoarthropathy].
Tomiie F; Yamamoto A; Murakami K; Hamaoka K
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Dec; 42(12):1127-36. PubMed ID: 6892060
[No Abstract] [Full Text] [Related]
12. Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.
Silove ED; Roberts DG; de Giovanni JV
Arch Dis Child; 1985 Nov; 60(11):1025-30. PubMed ID: 3865636
[TBL] [Abstract][Full Text] [Related]
13. Administration of E-type prostaglandins in ductus-dependent congenital heart disease.
Silove ED
Pediatr Cardiol; 1982; 2(4):303-5. PubMed ID: 6956847
[No Abstract] [Full Text] [Related]
14. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant.
Strauss A; Modanlou HD; Gyepes M; Wittner R
Am J Dis Child; 1982 Oct; 136(10):934-6. PubMed ID: 6889810
[TBL] [Abstract][Full Text] [Related]
15. [Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus].
Hruda J; Samánek M; First T; Vorísková M; Skovránek J
Cesk Pediatr; 1985 May; 40(5):257-62. PubMed ID: 3860302
[No Abstract] [Full Text] [Related]
16. Pharmacology: Prostin VR.
Hopkins SJ
Nurs Mirror; 1982 Aug; 155(5):48. PubMed ID: 6921719
[No Abstract] [Full Text] [Related]
17. The ductus arteriosus: why and how to manipulate its patency.
Drummond WH; Bucciarelli RL; Gessner IH
J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
[No Abstract] [Full Text] [Related]
18. Prostaglandin E1 in infants with pulmonary atresia.
Weir EK; Matisonn RE; Losman E; Chesler E
S Afr Med J; 1978 Oct; 54(17):700-2. PubMed ID: 741285
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological manipulation of the ductus arteriosus.
Silove ED
Arch Dis Child; 1986 Sep; 61(9):827-9. PubMed ID: 3767410
[No Abstract] [Full Text] [Related]
20. Exogenous prostaglandin administration and pseudo-Bartter syndrome.
Langhendries JP; Thiry V; Bodart E; Delfosse G; Whitofs L; Battisti O; Bertrand JM
Eur J Pediatr; 1989 Dec; 149(3):208-9. PubMed ID: 2612511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
